Kawasaki disease patients homozygous for the rs12252‐C variant of interferon‐induced transmembrane protein‐3 are significantly more likely to develop coronary artery lesions
Saved in:
| Main Authors: | Neil E. Bowles, Cammon B. Arrington, Keiichi Hirono, Tsuneyuki Nakamura, Long Ngo, Yin Shen Wee, Fukiko Ichida, John H. Weis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-07-01
|
| Series: | Molecular Genetics & Genomic Medicine |
| Online Access: | https://doi.org/10.1002/mgg3.79 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring Clinical and Imaging Differences in COVID-19: an Observational Approach to the IFITM3 rs12252 Polymorphism
by: Mitrea A, et al.
Published: (2025-04-01) -
Interferon-Induced Transmembrane Protein 3 rs34481144 C/T Genotype and Clinical Parameters Related to Progression of COVID-19
by: Melika Gholami, et al.
Published: (2023-01-01) -
A membrane topology model for human interferon inducible transmembrane protein 1.
by: Stuart Weston, et al.
Published: (2014-01-01) -
CD32a polymorphism rs1801274 affects the risk of Kawasaki disease
by: Zhiyong Wang, et al.
Published: (2020-01-01) -
Chicken interferon-induced transmembrane proteins inhibit Newcastle disease virus infection by affecting viral entry and W protein expression
by: Jing Chen, et al.
Published: (2025-05-01)